Literature DB >> 23881344

Odontoid infiltration and spinal compression in Farber Disease: reversal by haematopoietic stem cell transplantation.

Andrea Jarisch1, Colin G Steward, Jan Sörensen, Luciana Porto, Matthias Kieslich, Thomas Klingebiel, Peter Bader.   

Abstract

Farber disease (FD) is a lysosomal storage disorder caused by accumulation of ceramide in various organs and tissues, most notably the central nervous system, subcutaneous tissues and respiratory tract. We report a girl who developed major destructive bone involvement, which affected the odontoid process and produced spinal compression at 9 years of age. Bone involvement was proven histologically but resolved, as assessed by serial MRI scanning, following matched unrelated donor haematopoietic stem cell transplantation. This transplant resulted in only partial donor chimerism (less than 10 % donor cells in peripheral blood), yet this was sufficient to almost normalize acid ceramidase levels in leukocytes and to produce dramatic improvements in subcutaneous nodules and joint mobility as well as the beneficial effect on the involved bone. Unfortunately, the transplant was rejected after 2 years but the patient was rescued from an aplastic state by successful haploidentical peripheral blood stem cell transplantation and remained a full donor chimera without recurrence of the bone involvement and with steadily improving mobility at the age of 17 years. We describe an FD patient who presented with severe destruction of the odontoid by inflammatory tissue which was reversed after long-term control achieved by allogeneic hematopoietic stem cell transplantation. After extensive literature search, we believe that this is the first report of bony involvement in Farber disease.

Entities:  

Mesh:

Year:  2013        PMID: 23881344     DOI: 10.1007/s00431-013-2098-0

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  9 in total

1.  Successful hematopoietic stem cell transplantation in Farber disease.

Authors:  Josef Vormoor; Karoline Ehlert; Andreas H Groll; Hans-Georg Koch; Michael Frosch; Johannes Roth
Journal:  J Pediatr       Date:  2004-01       Impact factor: 4.406

Review 2.  Hemopoietic chimerism following stem cell transplantation.

Authors:  Shaun R McCann; Mireille Crampe; Karen Molloy; Mark Lawler
Journal:  Transfus Apher Sci       Date:  2005-02       Impact factor: 1.764

3.  Autologous transplantation of lentivector/acid ceramidase-transduced hematopoietic cells in nonhuman primates.

Authors:  Jagdeep S Walia; Anton Neschadim; Orlay Lopez-Perez; Abdulfatah Alayoubi; Xin Fan; Stéphane Carpentier; Melissa Madden; Chyan-Jang Lee; Fred Cheung; David A Jaffray; Thierry Levade; J Andrea McCart; Jeffrey A Medin
Journal:  Hum Gene Ther       Date:  2011-03-25       Impact factor: 5.695

4.  A lipid metabolic disorder: disseminated lipogranulomatosis; a syndrome with similarity to, and important difference from, Niemann-Pick and Hand-Schüller-Christian disease.

Authors:  S FARBER
Journal:  AMA Am J Dis Child       Date:  1952-10

5.  In vivo delivery of human acid ceramidase via cord blood transplantation and direct injection of lentivirus as novel treatment approaches for Farber disease.

Authors:  Shobha Ramsubir; Takahiro Nonaka; Carmen Bedia Girbés; Stéphane Carpentier; Thierry Levade; Jeffrey A Medin
Journal:  Mol Genet Metab       Date:  2008-09-20       Impact factor: 4.797

6.  Correction of odontoid dysplasia following bone-marrow transplantation and engraftment (in Hurler syndrome MPS 1H).

Authors:  S H Hite; C Peters; W Krivit
Journal:  Pediatr Radiol       Date:  2000-07

7.  Bone marrow transplantation for infantile ceramidase deficiency (Farber disease).

Authors:  A M Yeager; K A Uhas; C D Coles; P C Davis; W L Krause; H W Moser
Journal:  Bone Marrow Transplant       Date:  2000-08       Impact factor: 5.483

8.  Hypoplasia of the odontoid with atlanto-axial subluxation in Hurler's syndrome.

Authors:  S L Thomas; M H Childress; B Quinton
Journal:  Pediatr Radiol       Date:  1985

9.  Farber disease: clinical presentation, pathogenesis and a new approach to treatment.

Authors:  Karoline Ehlert; Michael Frosch; Natalja Fehse; Axel Zander; Johannes Roth; Josef Vormoor
Journal:  Pediatr Rheumatol Online J       Date:  2007-06-29       Impact factor: 3.054

  9 in total
  5 in total

1.  Markedly perturbed hematopoiesis in acid ceramidase deficient mice.

Authors:  Shaalee Dworski; Alexandra Berger; Caren Furlonger; Joshua M Moreau; Makoto Yoshimitsu; Jessa Trentadue; Bryan C Y Au; Christopher J Paige; Jeffrey A Medin
Journal:  Haematologica       Date:  2015-02-14       Impact factor: 9.941

2.  A cross-sectional quantitative analysis of the natural history of Farber disease: an ultra-orphan condition with rheumatologic and neurological cardinal disease features.

Authors:  Matthias Zielonka; Sven F Garbade; Stefan Kölker; Georg F Hoffmann; Markus Ries
Journal:  Genet Med       Date:  2017-10-19       Impact factor: 8.822

Review 3.  Inherited Paediatric Motor Neuron Disorders: Beyond Spinal Muscular Atrophy.

Authors:  Hooi Ling Teoh; Kate Carey; Hugo Sampaio; David Mowat; Tony Roscioli; Michelle Farrar
Journal:  Neural Plast       Date:  2017-05-28       Impact factor: 3.599

Review 4.  Acid ceramidase deficiency: Farber disease and SMA-PME.

Authors:  Fabian P S Yu; Samuel Amintas; Thierry Levade; Jeffrey A Medin
Journal:  Orphanet J Rare Dis       Date:  2018-07-20       Impact factor: 4.123

5.  [Paraplegia after hematopoietic stem cell transplantation].

Authors:  Y F Cheng; X J Huang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-04-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.